NEUROTOXIC DISORDERS

Clinical trials for NEUROTOXIC DISORDERS explained in plain language.

Never miss a new study

Get alerted when new NEUROTOXIC DISORDERS trials appear

Sign up with your email to follow new studies for NEUROTOXIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hope for chemo patients: drug may shield nerves from damage

Symptom relief Completed

This study tested whether a drug called mangafodipir could protect against nerve damage, a common and often disabling side effect of the chemotherapy drug oxaliplatin. It involved 23 cancer patients who were already experiencing moderate nerve pain but needed to continue oxalipla…

Matched conditions: NEUROTOXIC DISORDERS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief

Last updated Mar 30, 2026 14:33 UTC

NEUROTOXIC DISORDERS

Get alerted when new NEUROTOXIC DISORDERS trials appear

Hope for chemo patients: drug may shield nerves from damage